Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hilton Worldwide
HLT
|
+$717M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$580M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$444M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$406M |
| 5 |
Walt Disney
DIS
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.27B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$1.05B |
| 4 |
Apple
AAPL
|
+$768M |
| 5 |
NVIDIA
NVDA
|
+$530M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.2% |
| 2 | Technology | 7.55% |
| 3 | Healthcare | 7.22% |
| 4 | Energy | 6.62% |
| 5 | Consumer Discretionary | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NCI
3451
DELISTED
Navigant Consulting, Inc.
NCI
| $2.27M | ﹤0.01% |
140,879
-17,188
| -11% | -$271K |
|
|
NAVB
3452
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $2.27M | ﹤0.01% |
214,197
+33,700
| +19% | +$662K |
|
3453
NatWest
NWG
$75.3B
| $2.27M | ﹤0.01% |
448,799
+267,618
| +148% | +$1.88M |
|
3454
CALL
BlackBerry
BB
$4.98B
| $2.27M | ﹤0.01% |
338,100
+95,800
| +40% | +$669K |
|
3455
Iovance Biotherapeutics
IOVA
$1.82B
| $2.26M | ﹤0.01% |
279,351
+228,287
| +447% | +$1.43M |
|
3456
PUT
Crown Castle
CCI
$33.3B
| $2.26M | ﹤0.01% |
22,300
+22,100
| +11,050% | +$2.01M |
|
|
NYRT
3457
DELISTED
New York REIT, Inc.
NYRT
| $2.26M | ﹤0.01% |
24,432
-28,523
| -54% | -$2.76M |
|
3458
Paylocity
PCTY
$7.38B
| $2.26M | ﹤0.01% |
52,296
+18,404
| +54% | +$690K |
|
3459
CALL
Zions Bancorporation
ZION
$10.2B
| $2.26M | ﹤0.01% |
89,800
+38,500
| +75% | +$1.02M |
|
|
VLRS
3460
Controladora Vuela Compania de Aviacion
VLRS
$900M
| $2.25M | ﹤0.01% |
120,380
-299,129
| -71% | -$5.89M |
|
3461
PUT
Bunge Global
BG
$20.4B
| $2.25M | ﹤0.01% |
38,000
+27,100
| +249% | +$1.66M |
|
3462
PUT
TJX Companies
TJX
$174B
| $2.25M | ﹤0.01% |
58,200
+48,000
| +471% | +$1.83M |
|
|
RGLS
3463
DELISTED
Regulus Therapeutics
RGLS
| $2.25M | ﹤0.01% |
6,473
+22
| +0.3% | +$15.8K |
|
3464
Universal Electronics
UEIC
$57.8M
| $2.24M | ﹤0.01% |
31,018
+9,497
| +44% | +$623K |
|
3465
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $2.24M | ﹤0.01% |
25,038
-220,005
| -90% | -$19.3M |
|
3466
Genesco
GCO
$425M
| $2.24M | ﹤0.01% |
34,798
-27,964
| -45% | -$1.85M |
|
|
PERY
3467
DELISTED
Perry Ellis International Inc
PERY
| $2.24M | ﹤0.01% |
111,137
+9,193
| +9% | +$176K |
|
|
ZAYO
3468
CALL
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $2.23M | ﹤0.01% |
+80,000
| New | +$2.13M |
|
3469
Aegon
AEG
$14B
| $2.23M | ﹤0.01% |
749,456
-171,277
| -19% | -$644K |
|
3470
PUT
D.R. Horton
DHI
$40B
| $2.23M | ﹤0.01% |
70,700
+34,300
| +94% | +$1.05M |
|
3471
PUT
J.M. Smucker
SJM
$12.7B
| $2.23M | ﹤0.01% |
14,600
+4,000
| +38% | +$532K |
|
3472
Ezcorp Inc
EZPW
$1.83B
| $2.21M | ﹤0.01% |
292,496
-11,799
| -4% | -$66.5K |
|
|
ETFC
3473
CALL
DELISTED
E*Trade Financial Corporation
ETFC
| $2.2M | ﹤0.01% |
93,800
+43,800
| +88% | +$1.11M |
|
3474
St. Joe Company
JOE
$3.54B
| $2.2M | ﹤0.01% |
123,956
+54,804
| +79% | +$933K |
|
|
CA
3475
CALL
DELISTED
CA, Inc.
CA
| $2.2M | ﹤0.01% |
66,900
+26,800
| +67% | +$839K |
|
Similar funds
Goldman Sachs's Q2 2016 Portfolio in Review
As of Q2 2016, Goldman Sachs held 7,605 positions worth $306B, up 0.71% from $304B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs's Q2 2016 filing shows 546 new, 3,268 increased, 2,864 reduced and 595 closed positions. Its largest new stake was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 3,735,711 shares worth $87.8M. The largest sale was Pfizer, an estimated $2.27B.
By sector, the portfolio is most concentrated in Financials at 8.2% of assets, down from 8.6% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 3,735,711 shares worth $87.8M.
- Goldman Sachs added most to Hilton Worldwide in Q2 2016, an estimated $717M increase.
- Goldman Sachs's biggest Q2 2016 reduction was Pfizer, cutting an estimated $2.27B.
- Goldman Sachs fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $1.05B.
- Goldman Sachs's ten largest holdings make up 15% of its $306B portfolio in Q2 2016.
- Goldman Sachs opened 546 new positions and closed 595 in Q2 2016.
- Goldman Sachs's portfolio value rose 0.71% quarter-over-quarter to $306B.
Based on Goldman Sachs's 13F filing for Q2 2016, filed 15 Aug 2016.